Abstract:
Background:Blood transfusion provides a major rapid and effective treatment for transfusion
dependent anaemia patients including those with thalassemia, sickle cell anaemia,
myelodysplastic syndrome, aplastic anaemia and haemolytic anaemia. Unfortunately
transfusional iron overload among transfusion dependent anaemia patients has been shown to
be a potentially serious problem that is often overlooked because the symptoms are
nonspecific and often develop gradually. A number of diagnostic tests are available, but their
interpretation can be challenging. Once transfusional iron overload is diagnosed, the options
for treatment are relatively straightforward in the majority of individuals. However, untreated
individuals can develop life-threatening morbidity and mortality related to organ toxicity.
Thus, it is important to identify iron overload before organ damage occurs.
Objectives:The study was performed to determine the prevalence of transfusional iron
overload, to describe the clinical diagnosis,clinical presentation and iron status of individuals
with transfusion dependent anaemia at MNH.
Methodology: This was a descriptive, cross sectional hospital based study involving patients
from 2 years and abovewith transfusion dependent anemia who have received
≥10transfusions or ≥100mls/kg of red blood cells in their life time, attending inpatient and
outpatient hematology services at Muhimbili National Hospital. A structured questionnaire
wasused to obtain information on socio-demographic particulars, type of illnessand number
of blood transfusions one has received in certain period of time. Blood samples were drawn
for full blood count, serum ferritin, serum iron,serum transferrin and C-reactive protein.The
collected data were analyzed by using SPSS version 20.0.
Results: Majority of patients were aged between 2 and 17 years 59 (52.7%), followed by 18-
35 years 28 (25%). In a total of 112 study participants 60(53.6%) were males. Of these 112
study participants, majority were observed to have aplastic anaemia37(33%), followed by
acute leukemia 27 (24.1%).Most of the patients were observed to have had received blood
transfusion for more than 12 months.The clinical signs and symptoms that were observed in
transfusion dependent anaemia patients were tachycardia, bradycardia, skin
hyperpigmentation and hepatomegaly.Serum ferritin, iron, and transferrin saturation were
observed to be markedly elevated and transferrin was low. Of the 112 patients, 74.1% had
ferritin levels > 1000ng/ml and 71.4% had TSAT > 45%.
Conclusion:The prevalence of iron overload among transfusion dependent anaemia patients
at Muhimbili National Hospital was 72.5%. Serum ferritin and transferrin saturation were
observed to be significantly elevated in all clinical diagnoses observed in this study.
Recommendation: Having confirmed that iron overload is common among transfusion
dependent anaemia patients, there is a need of screening for iron overload in a patient with a
history of recurrent blood transfusion of ≥ 10 units or ≥ 100mls/kg in lifetime.
Ferritin level of > 1000ng/ml and TSAT of > 45% in a patient with the history of receiving
blood transfusion of ≥ 10 units or ≥ 100mls/kg in life time, chelation therapy should be
initiated since it is effective at reducing iron burden and preventing organ damage.
Serum ferritin and transferrin saturation are the easily available tests that can be used to
diagnose transfusional iron overload in our setup.